205 related articles for article (PubMed ID: 25068842)
1. Incidence and predictive factors for malignancies with dermatomyositis: a cohort from southern China.
Chen D; Yuan S; Wu X; Li H; Qiu Q; Zhan Z; Ye Y; Lian F; Liang L; Xu H; Yang X
Clin Exp Rheumatol; 2014; 32(5):615-21. PubMed ID: 25068842
[TBL] [Abstract][Full Text] [Related]
2. Incidence and predictive factors for malignancies in 136 Japanese patients with dermatomyositis, polymyositis and clinically amyopathic dermatomyositis.
Azuma K; Yamada H; Ohkubo M; Yamasaki Y; Yamasaki M; Mizushima M; Ozaki S
Mod Rheumatol; 2011 Apr; 21(2):178-83. PubMed ID: 20922453
[TBL] [Abstract][Full Text] [Related]
3. Malignancy in dermatomyositis: A retrospective paired case-control study of 202 patients from Central China.
Chang L; Zhang L; Jia H; Nie Z; Zhang L
Medicine (Baltimore); 2020 Aug; 99(34):e21733. PubMed ID: 32846794
[TBL] [Abstract][Full Text] [Related]
4. Idiopathic inflammatory myopathy associated with malignancy: a retrospective cohort of 151 Korean patients with dermatomyositis and polymyositis.
So MW; Koo BS; Kim YG; Lee CK; Yoo B
J Rheumatol; 2011 Nov; 38(11):2432-5. PubMed ID: 21844145
[TBL] [Abstract][Full Text] [Related]
5. Dermatomyositis and malignancy: a retrospective study of 115 cases.
Zhang W; Jiang SP; Huang L
Eur Rev Med Pharmacol Sci; 2009; 13(2):77-80. PubMed ID: 19499841
[TBL] [Abstract][Full Text] [Related]
6. Complex repetitive discharge on electromyography as a risk factor for malignancy in idiopathic inflammatory myopathy.
Kim NR; Nam EJ; Kang JW; Song HS; Im CH; Kang YM
Korean J Intern Med; 2014 Nov; 29(6):814-21. PubMed ID: 25378981
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics and prognostic analysis of Chinese dermatomyositis patients with malignancies.
Shao C; Li S; Sun Y; Zhang Y; Xu K; Zhang X; Huang H
Medicine (Baltimore); 2020 Aug; 99(34):e21899. PubMed ID: 32846853
[TBL] [Abstract][Full Text] [Related]
8. Routine vs extensive malignancy search for adult dermatomyositis and polymyositis: a study of 40 patients.
Sparsa A; Liozon E; Herrmann F; Ly K; Lebrun V; Soria P; Loustaud-Ratti V; Bouyssou-Gauthier ML; Boulinguez S; Bédane C; Jauberteau MO; Vidal E; Bonnetblanc JM
Arch Dermatol; 2002 Jul; 138(7):885-90. PubMed ID: 12071815
[TBL] [Abstract][Full Text] [Related]
9. Clinical characteristics and prognosis of polymyositis and dermatomyositis associated with malignancy: a 25-year retrospective study.
Motomura K; Yamashita H; Yamada S; Takahashi Y; Kaneko H
Rheumatol Int; 2019 Oct; 39(10):1733-1739. PubMed ID: 31444556
[TBL] [Abstract][Full Text] [Related]
10. Predicting factors of malignancy in dermatomyositis and polymyositis: a case-control study.
Chen YJ; Wu CY; Shen JL
Br J Dermatol; 2001 Apr; 144(4):825-31. PubMed ID: 11298544
[TBL] [Abstract][Full Text] [Related]
11. Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: A retrospective case-control study.
Wu C; Wang Q; He L; Yang E; Zeng X
PLoS One; 2018; 13(2):e0192491. PubMed ID: 29474373
[TBL] [Abstract][Full Text] [Related]
12. [The predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis/dermatomyositis].
Wang PZ; Guan JL; Han XH
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jun; 31(6):417-20. PubMed ID: 19031800
[TBL] [Abstract][Full Text] [Related]
13. Reappraisal of the incidence, various types and risk factors of malignancies in patients with dermatomyositis and polymyositis in Taiwan.
Hsu JL; Liao MF; Chu CC; Kuo HC; Lyu RK; Chang HS; Chen CM; Wu YR; Chang KH; Weng YC; Chang CW; Chiang HI; Cheng CK; Lee PW; Huang CC; Ro LS
Sci Rep; 2021 Feb; 11(1):4545. PubMed ID: 33633147
[TBL] [Abstract][Full Text] [Related]
14. Incidence and impact of interstitial lung disease and malignancy in patients with polymyositis, dermatomyositis, and clinically amyopathic dermatomyositis: a retrospective cohort study.
Ikeda S; Arita M; Misaki K; Mishima S; Takaiwa T; Nishiyama A; Ito A; Furuta K; Yokoyama T; Tokioka F; Noyama M; Yoshioka H; Ishida T
Springerplus; 2015; 4():240. PubMed ID: 26101728
[TBL] [Abstract][Full Text] [Related]
15. Elevated Erythrocyte Sedimentation Rate Is Predictive of Interstitial Lung Disease and Mortality in Dermatomyositis: a Korean Retrospective Cohort Study.
Go DJ; Lee EY; Lee EB; Song YW; Konig MF; Park JK
J Korean Med Sci; 2016 Mar; 31(3):389-96. PubMed ID: 26955239
[TBL] [Abstract][Full Text] [Related]
16. Predictive factors and unfavourable prognostic factors of interstitial lung disease in patients with polymyositis or dermatomyositis: a retrospective study.
Ji SY; Zeng FQ; Guo Q; Tan GZ; Tang HF; Luo YJ; Tang ZQ; Han YF
Chin Med J (Engl); 2010 Mar; 123(5):517-22. PubMed ID: 20367973
[TBL] [Abstract][Full Text] [Related]
17. Factors associated with underlying malignancy in a retrospective cohort of 121 patients with dermatomyositis.
Fardet L; Dupuy A; Gain M; Kettaneh A; Chérin P; Bachelez H; Dubertret L; Lebbe C; Morel P; Rybojad M
Medicine (Baltimore); 2009 Mar; 88(2):91-97. PubMed ID: 19282699
[TBL] [Abstract][Full Text] [Related]
18. Cancer risk in dermatomyositis: a systematic review of the literature.
Di Rollo D; Abeni D; Tracanna M; Capo A; Amerio P
G Ital Dermatol Venereol; 2014 Oct; 149(5):525-37. PubMed ID: 24975953
[TBL] [Abstract][Full Text] [Related]
19. Risk of Malignancy in Dermatomyositis and Polymyositis.
Qiang JK; Kim WB; Baibergenova A; Alhusayen R
J Cutan Med Surg; 2017; 21(2):131-136. PubMed ID: 27534779
[TBL] [Abstract][Full Text] [Related]
20. [Clinical features and risk factors associated with interstitial lung disease in patients with classic dermatomyositis or clinical amyopathic dermatomyositis].
Lin H; Liang Y; Wang Y; Cen XM; Yin G; Xie QB
Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):805-9. PubMed ID: 24325117
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
